Outsourcing Exceeds Expectations
Outsourcing Maximises Lilly's Cymbalta Launch
In Quintiles, Lilly found an ally with a kindred commitment to a best-in-class culture, plus a readiness to innovate in a challanging market.
White Paper
New Voices, New Opportunities: Toward a Patient-Centric Biopharmaceutical Commercialization Model
Biopharmaceutical companies must learn to navigate the increasingly tricky waters of commercializing products by adjusting to the needs of a new set of stakeholders.
Explore biopharma, payer and patient viewpoints of the New Health landscape.
